Keith Van Haren

Keith Van Haren's projects emphasize collaborative solutions for complex neurological disorders, particularly those affecting children. As an Assistant Professor of Neurology and Pediatrics at Stanford Medicine, Dr. Van Haren is dedicated to advancing the understanding and treatment of neurological conditions. His expertise lies in leukodystrophies and autoimmune diseases of the nervous system, with a special focus on child neurology.

Dr. Van Haren's research is at the forefront of developing innovative treatments for brain disorders. He is particularly noted for his work on a novel gene therapy approach aimed at alleviating X-linked adrenoleukodystrophy, a rare genetic disorder. This pioneering work not only seeks to improve patient outcomes but also contributes to the broader field of gene therapy in neurology.

In addition to his research, Dr. Van Haren is actively involved in several professional organizations, where he collaborates with fellow experts to push the boundaries of neurological science. His role on the Child Neurology Foundation's scientific advisory board underscores his commitment to advancing pediatric neurology and supporting families affected by neurological disorders.

Dr. Van Haren's contributions to the field are marked by his dedication to integrating cutting-edge research with clinical practice, ensuring that his work has a direct impact on patient care. His efforts in gene therapy and his focus on autoimmune diseases of the nervous system highlight his commitment to finding effective treatments for some of the most challenging neurological conditions.

Through his work, Dr. Van Haren continues to inspire both his colleagues and the next generation of neurologists, fostering a collaborative environment that encourages innovation and excellence in the field of neurology. His dedication to improving the lives of patients with neurological disorders remains a driving force behind his research and clinical endeavors.